When Patients Present With Direct-to-Consumer Pharmacogenomic Test Results
Mayo Clin Proc
.
2025 Jan 14:S0025-6196(24)00546-9.
doi: 10.1016/j.mayocp.2024.10.016.
Online ahead of print.
Authors
Roseann S Donnelly
1
,
Houriya Ayoubieh
2
,
Elizabeth L Kudron
3
,
Rachel Mills
4
,
Tracey Weiler
5
,
Philip E Empey
6
;
Direct-to-Consumer Genetic Testing Project Group of the National Human Genome Research Institute Inter-Society Coordinating Committee for Practitioner Education in Genomics
Affiliations
1
Department of Pharmacy Practice, Massachusetts College of Pharmacy and Health Sciences, Boston, MA. Electronic address:
[email protected]
.
2
Department of Medical Education, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center, El Paso, TX.
3
Department of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO.
4
Genetic Counseling Program, The University of North Carolina at Greensboro, Greensboro, NC.
5
Department of Medical Education, Herbert Wertheim College of Medicine, Florida International University, Miami, FL.
6
Department of Pharmacy and Therapeutics, Center for Clinical Pharmaceutical Sciences, University of Pittsburgh School of Pharmacy, Pittsburgh, PA.
PMID:
39818680
DOI:
10.1016/j.mayocp.2024.10.016
No abstract available